The expression of MnSOD and E-cadherin and its biological signficance in nasopharyngeal carcinoma
10.3760/cma.j.issn.1004-4221.2009.01.037
- VernacularTitle:锰超氧化物歧化酶和E-钙黏蛋白在鼻咽癌组织中的表达及意义
- Author:
Qing LIU
;
Yadi WANG
;
Zhiming DONG
;
Xiaoling WANG
;
Shanghua JING
- Publication Type:Journal Article
- Keywords:
Nasopharyngeal neoplasms;
Manganese superoxide dismutase;
E-cadherin;
Ra diosentivity;
Prognosis
- From:
Chinese Journal of Radiation Oncology
2009;18(1):37-41
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the expression of MnSOD and E-cadhefin in nasopharyngeal carcinoma(NPC) tissue and its relationship with clinicopathological features and prognosis. Methods The expression of MnSOD and E-cadherin were detected by immunohistochemistry method in 60 NPC patients. Results Of the whole group,lymph node positive group and lymph node negative group,the strong positive rate of MnSOD protein was 47% (28/60) ,49% (25/51 patients) and 33% (3/9) (x2 =0.76,P =0.382), respectively.The corresponding strong positive rate of E-cadherin protein was 47% (28/60) ,43% (22/51) and 78% (7/9) (x2 =3.69,P =0.047) ,respectively.The expression of MnSOD increased with T stage and N stage.The higher expression of MnSOD was significantly associated with the larger size of metastatic lymph node(r =0.46 ,P =0.002) ,more radioresistance and poorer prognosis,but not with the region of lymph node metastasis(r =0.223,P = 0.116).The lower expression of E-cadherin was closely relevant with higher N stage and the smaller region of lymph node metastasis(r =-0.33,P = 0.020),but not with T stage,lymph node size or radiosensitivity(r =-2.19,P=0.093;r=-0.07,P=0.623;r=-0.18,P=0.170).Multi variate analysis showed that MnSOD and E-canherin were independent prognostic factors (x2= 4.45,P = 0.035;x2 =5.12,P=0.024). Conclusions High expression of MnSOD may stimulate tumor growth and reduce radiosensitivity.High expression of E-cadherin may inhibit lymphatic metastasis,while has no rela tionship with tumor growth and invasion.MnSOD and E-cadherin could affect the prognosis of NPC patients.
